Free tool
FAERS Monitor: Methotrexate Sodium
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 008085 or its brand name (Methotrexate Sodium, Methotrexate Sodium). Reports on generic versions are filed under their own applications.
Reports
76,327
Serious
47,719
63% of reports
Hospitalization
16,168
Death reported
4,446
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective19,726
- drug hypersensitivity7,824
- off label use6,466
- rheumatoid arthritis5,720
- drug intolerance5,635
- nausea5,389
- arthralgia5,078
- pain5,067
- condition aggravated4,721
- fatigue4,529
- joint swelling3,552
- treatment failure3,321
- alopecia3,254
- rash3,246
- diarrhoea2,829
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 767 |
| 2005 | 506 |
| 2006 | 181 |
| 2007 | 249 |
| 2008 | 267 |
| 2009 | 263 |
| 2010 | 161 |
| 2011 | 385 |
| 2012 | 682 |
| 2013 | 772 |
| 2014 | 513 |
| 2015 | 1,132 |
| 2016 | 4,126 |
| 2017 | 10,226 |
| 2018 | 12,491 |
| 2019 | 9,172 |
| 2020 | 6,834 |
| 2021 | 4,865 |
| 2022 | 6,005 |
| 2023 | 5,993 |
| 2024 | 5,136 |
| 2025 | 3,824 |
| 2026 | 1,777 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,977,832 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug intoleranceSignal | 5,635 | 17.0 | 16.6 | 80,302 |
| rheumatoid arthritisSignal | 5,720 | 14.6 | 14.2 | 68,995 |
| drug hypersensitivitySignal | 7,824 | 11.6 | 11.3 | 73,147 |
| treatment failureSignal | 3,321 | 11.5 | 11.1 | 30,565 |
| joint swellingSignal | 3,552 | 8.3 | 8.1 | 22,338 |
| alopeciaSignal | 3,254 | 4.6 | 4.5 | 9,177 |
| condition aggravatedSignal | 4,721 | 4.3 | 4.2 | 12,076 |
| drug ineffectiveSignal | 19,726 | 4.2 | 4.1 | 49,990 |
| arthralgiaSignal | 5,078 | 3.4 | 3.3 | 8,642 |
| painSignal | 5,067 | 2.3 | 2.2 | 3,734 |
| rashSignal | 3,246 | 2.1 | 2.0 | 1,793 |
| off label useSignal | 6,466 | 2.0 | 2.0 | 3,563 |
| nausea | 5,389 | 1.9 | 1.8 | 2,299 |
| fatigue | 4,529 | 1.6 | 1.6 | 1,070 |
| diarrhoea | 2,829 | 1.2 | 1.2 | 104 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.